Postexit surface engineering of retroviral/lentiviral vectors

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Metzner, Christoph ^a   Kochan, Feliks ^a   Dangerfield, John A ^b  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b Anovasia Pte Ltd   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; RETROVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; BIOMEDICAL ENGINEERING; BIOMEDICINE; BIOTECHNOLOGY; BIOTINYLATION; CELL NUCLEUS; CHEMICAL MODIFICATION; GENOTYPE; INFLUENZA VIRUS; IODINATION; LENTIVIRINAE; MEASLES VIRUS; NONHUMAN; PHENOTYPE; RETROVIRUS; REVIEW; VESICULAR STOMATITIS VIRUS; VIRAL GENETICS; VIRUS PARTICLE; GENE VECTOR; GENETIC ENGINEERING; GENETICS; PHYSIOLOGY; PROCEDURES; SURFACE PROPERTY; VIRION; METHODOLOGY;

GENETIC ENGINEERING; GENETIC VECTORS; LENTIVIRUS; RETROVIRIDAE; SURFACE PROPERTIES; VIRION;

EID: 84877307370     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/253521     Document Type: Review

References (66)

1. Metzner C., Dangerfield J. A., Xu K., Surface modification of retroviral vectors for gene therapy. Viral Gene Therapy 2011 Rijeka, Croatia InTech
2. Segura M. M., Kamen A. A., Garnier A., Overview of current scalable methods for purification of viral vectors. Methods in Molecular Biology 2011 737 89 116 10.1007/978-1-61779-095-9-4
3. Rodrigues T., Carrondo M. J. T., Alves P. M., Cruz P. E., Purification of retroviral vectors for clinical application: biological implications and technological challenges. Journal of Biotechnology 2007 127 3 520 541 2-s2.0-34248526597 10.1016/j.jbiotec.2006.07.028 (Pubitemid 44827399)
4. Kaikkonen M. U., Lesch H. P., Pikkarainen J., Räty J. K., Vuorio T., Huhtala T., Taavitsainen M., Laitinen T., Tuunanen P., Gröhn O., Närvänen A., Airenne K. J., Ylä-Herttuala S., (Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery. Gene Therapy 2009 16 7 894 904 2-s2.0-67749107959 10.1038/gt.2009.47
5. Breun S., Salmons B., Günzburg W. H., Baumann J. G., Protection of MLV vector particles from human complement. Biochemical and Biophysical Research Communications 1999 264 1 1 5 2-s2.0-0033554604 10.1006/bbrc.1999.1474 (Pubitemid 29500453)
6. Waehler R., Russell S. J., Curiel D. T., Engineering targeted viral vectors for gene therapy. Nature Reviews Genetics 2007 8 8 573 587 2-s2.0-34447535345 10.1038/nrg2141 (Pubitemid 47077278)
7. Metzner C., Mosteg M. M., Günzburg W. H., Salmons B., Dangerfield J. A., Association of glycosylphosphatidylinositol-anchored protein with retroviral particles. FASEB Journal 2008 22 8 2734 2739 2-s2.0-48749086245 10.1096/fj.08-108217
8. Montelaro R. C., Rueckert R. R., On the use of chloramine T to iodinate specifically the surface proteins of intact enveloped viruses. Journal of General Virology 1975 29 1 127 131 2-s2.0-0016763963
9. Neda H., Wu C. H., Wu G. Y., Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity. The Journal of Biological Chemistry 1991 266 22 14143 14146 2-s2.0-0026322077 (Pubitemid 21907471)
10. Croyle M. A., Callahan S. M., Auricchio A., Schumer G., Linse K. D., Wilson J. M., Brunner L. J., Kobinger G. P., PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum. Journal of Virology 2004 78 2 912 921 2-s2.0-0347949564 10.1128/JVI.78.2.912- 921.2004 (Pubitemid 38067612)
11. Yang G., Zhong Q., Huang W., Reiser J., Schwarzenberger P., Retrovirus molecular conjugates: a versatile and efficient gene transfer vector system for primitive human hematopoietic progenitor cells. Cancer Gene Therapy 2006 13 5 460 468 2-s2.0-33645847237 10.1038/sj.cgt.7700911
12. Skulstad S., Rodahl E., Jakobsen K., Langeland N., Haarr L., Labeling of surface protein of herpes simplex virus type 1 using a modified biotin-streptavidin system. Virus Research 1995 37 3 253 270 2-s2.0-0028983016 10.1016/0168-1702(95)00036-P
13. Wong S., Kwon Y. J., Synthetically functionalized retroviruses produced from the bioorthogonally engineered cell surface. Bioconjugate Chemistry 2011 22 2 151 155 2-s2.0-79951696910 10.1021/bc100516h
14. Hadac E. M., Federspiel M. J., Chernyy E., Tuzikov A., Korchagina E., Bovin N. V., Russell S., Henry S. M., Fluorescein and radiolabeled function-spacer-lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions. Journal of Virological Methods 2011 176 1-2 78 84 2-s2.0-79960592246 10.1016/j.jviromet.2011.06.005
15. Metzner C., Kochan F., Dangerfield J. A., Fluorescence molecular painting of enveloped viruses. Molecular Biotechnology 2013 53 1 9 18 10.1007/s12033-012-9616-6
16. Schellingerhout D., Bogdanov A., Marecos E., Spear M., Breakefield X., Weissleder R., Mapping the in vivo distribution of herpes simplex virions. Human Gene Therapy 1998 9 11 1543 1549 2-s2.0-0032551583 (Pubitemid 28382956)
17. Lear M. J., Reux B., Sekar K., Dangerfield J. A., Metzner C., Chemical synthesis, modification and mimicry of the GPI anchor. GPI Membrane Anchors-The Much Needed Link 2010 Oak Park, Ill, USA Bentham Science 88 115
18. Kato K., Itoh C., Yasukouchi T., Nagamune T., Rapid protein anchoring into the membranes of mammalian cells using oleyl chain and poly(ethylene glycol) derivatives. Biotechnology Progress 2004 20 3 897 904 2-s2.0-2942735389 10.1021/bp0342093 (Pubitemid 38784030)
19. Smith R. A. G., Targeting anticomplement agents. Biochemical Society Transactions 2002 30 6 1037 1041 2-s2.0-0036864134 10.1042/BST0301037 (Pubitemid 36002401)
20. Roux P., Jeanteur P., Piechaczyk M., A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses. Proceedings of the National Academy of Sciences of the United States of America 1989 86 23 9079 9083 2-s2.0-0024351653 10.1073/pnas.86.23.9079 (Pubitemid 20010368)
21. Morizono K., Xie Y., Helguera G., Daniels T. R., Lane T. F., Penichet M. L., Chen I. S. Y., A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide. Journal of Gene Medicine 2009 11 8 655 663 2-s2.0-70349508864 10.1002/jgm.1345
22. Nesbeth D., Williams S. L., Chan L., Brain T., Slater N. K. H., Farzaneh F., Darling D., Metabolic biotinylation of lentiviral pseudotypes for scalable paramagnetic microparticle-dependent manipulation. Molecular Therapy 2006 13 4 814 822 2-s2.0-33645517870 10.1016/j.ymthe.2005.09.016
23. Chen R., Folarin N., Ho V. H., McNally D., Darling D., Farzaneh F., Slater N. K., Affinity recovery of lentivirus by diaminopelargonic acid mediated desthiobiotin labelling. Journal of Chromatography B 2010 878 22 1939 1945 2-s2.0-77956686263
24. Kaikkonen M. U., Viholainen J. I., Närvänen A., Ylä-Herttuala S., Airenne K. J., Targeting and purification of metabolically biotinylated baculovirus. Human Gene Therapy 2008 19 6 589 600 2-s2.0-46249111263 10.1089/hum.2007.177 (Pubitemid 351913529)
25. Snitkovsky S., Young J. A. T., Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein. Virology 2002 292 1 150 155 2-s2.0-0036058346 10.1006/viro.2001.1314
26. Snitkovsky S., Niederman T. M. J., Carter B. S., Mulligan R. C., Young J. A. T., A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor. Journal of Virology 2000 74 20 9540 9545 2-s2.0-0033813743 10.1128/JVI.74.20.9540-9545.2000
27. Snitkovsky S., Niederman T. M. J., Mulligan R. C., Young J. A. T., Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein. Journal of Virology 2001 75 3 1571 1575 2-s2.0-0035152288 10.1128/JVI.75.3.1571-1575.2001 (Pubitemid 32094717)
28. Baek H., Uchida H., Jun K., Kim J. H., Kuroki M., Cohen J. B., Glorioso J. C., Kwon H., Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells. Molecular Therapy 2011 19 3 507 514 2-s2.0-79952190298 10.1038/mt.2010.207
29. Brandão J. G., Scheper R. J., Lougheed S. M., Curiel D. T., Tillman B. W., Gerritsen W. R., van den Eertwegh A. J. M., Pinedo H. M., Haisma H. J., de Gruijl T. D., CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation. Vaccine 2003 21 19-20 2268 2272 2-s2.0-12444345503 10.1016/S0264-410X(03)00050-1 (Pubitemid 36561319)
30. Nettelbeck D. M., Miller D. W., Jérôme V., Zuzarte M., Watkins S. J., Hawkins R. E., Müller R., Kontermann R. E., Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105). Molecular Therapy 2001 3 6 882 891 2-s2.0-0034963191 10.1006/mthe.2001.0342 (Pubitemid 32611298)
31. Tai C. K., Logg C. R., Park J. M., Anderson W. F., Press M. F., Kasahara N., Antibody-mediated targeting of replication-competent retroviral vectors. Human Gene Therapy 2003 14 8 789 802 2-s2.0-0038021046 10.1089/ 104303403765255174 (Pubitemid 36623515)
32. Morizono K., Xie Y., Ringpis G. E., Johnson M., Nassanian H., Lee B., Wu L., Chen I. S. Y., Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nature Medicine 2005 11 3 346 352 2-s2.0-16244394824 10.1038/nm1192 (Pubitemid 40460565)
33. Banerjee P. S., Carrico I. S., Chemoselective modification of viral proteins bearing metabolically introduced "clickable" amino acids and sugars. Methods in Molecular Biology 2011 751 55 66 10.1007/978-1-61779-151-2-5
34. Dhar T., Mootz H. D., Modification of transmembrane and GPI-anchored proteins on living cells by efficient protein trans-splicing using the Npu DnaE intein. Chemical Communications 2011 47 11 3063 3065 2-s2.0-79952850251 10.1039/c0cc04172f
35. Bischof D., Cornetta K., Flexibility in cell targeting by pseudotyping lentiviral vectors. Methods in Molecular Biology 2010 614 53 68 2-s2.0-77953940485 10.1007/978-1-60761-533-0-3
36. Ryu B. Y., Zavorotinskaya T., Trentin B., Albritton L. M., The block to membrane fusion differs with the site of ligand insertion in modified retroviral envelope proteins. Journal of General Virology 2008 89 part 4 1049 1058 2-s2.0-45549098499 10.1099/vir.0.83445-0
37. Anliker B., Abel T., Kneissl S., Hlavaty J., Caputi A., Brynza J., Schneider I. C., Münch R. C., Petznek H., Kontermann R. E., Koehl U., Johnston I. C. D., Keinänen K., Müller U. C., Hohenadl C., Monyer H., Cichutek K., Buchholz C. J., Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors. Nature Methods 2010 7 11 929 935 2-s2.0-78049345098 10.1038/nmeth.1514
38. Croyle M. A., Chirmule N., Zhang Y., Wilson J. M., PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver. Human Gene Therapy 2002 13 15 1887 1900 2-s2.0-0036412085 10.1089/104303402760372972 (Pubitemid 35292683)
39. Croyle M. A., Yu Q. C., Wilson J. M., Development of a rapid method for the pegylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions. Human Gene Therapy 2000 11 12 1713 1722 2-s2.0-0034632396
40. Frost E. H. E., Radioactive labelling of viruses: an iodination technique preserving biological properties. Journal of General Virology 1977 35 1 181 185 2-s2.0-0017332942 (Pubitemid 8066873)
41. Zeng Y., Ramya T. N. C., Dirksen A., Dawson P. E., Paulson J. C., High-efficiency labeling of sialylated glycoproteins on living cells. Nature Methods 2009 6 3 207 209 2-s2.0-61449097424 10.1038/nmeth.1305
42. Schellingerhout D., Bogdanov A. A., Viral imaging in gene therapy: noninvasive demonstration of gene delivery and expression. Neuroimaging Clinics of North America 2002 12 4 571 581 2-s2.0-0036865890 10.1016/S1052-5149(02) 00034-5 (Pubitemid 36015492)
43. Lan C. C., Blake D., Henry S., Love D. R., Fluorescent function-spacer-lipid construct labelling allows for real-time in vivo imaging of cell migration and behaviour in zebrafish (Danio rerio). Journal of Fluorescence 2012 22 4 1055 1063 10.1007/s10895-012-1043-3
44. Akin D., Li H., Bashir R., Real-time virus trapping and fluorescent imaging in microfluidic devices. Nano Letters 2004 4 2 257 259 2-s2.0-1442275476 10.1021/nl034987p (Pubitemid 38292897)
45. Oliver C., Blake D., Henry S., Modeling transfusion reactions and predicting in vivo cell survival with kodecytes. Transfusion 2011 51 8 1723 1730 10.1111/j.1537-2995.2010.03034.x
46. Oliver C., Blake D., Henry S., In vivo neutralization of anti-A and successful transfusion of A antigen-incompatible red blood cells in an animal model. Transfusion 2011 51 12 2664 2675 10.1111/j.1537-2995.2011.03184.x
47. Heathcote D., Carroll T., Wang J. J., Flower R., Rodionov I., Tuzikov A., Bovin N., Henry S., Novel antibody screening cells, MUT+Mur kodecytes, created by attaching peptides onto red blood cells. Transfusion 2010 50 3 635 641 2-s2.0-77649200591 10.1111/j.1537-2995.2009.02480.x
48. Frame T., Carroll T., Korchagina E., Bovin N., Henry S., Synthetic glycolipid modification of red blood cell membranes. Transfusion 2007 47 5 876 882 2-s2.0-34247646170 10.1111/j.1537-2995.2007.01204.x (Pubitemid 46669002)
49. Eisenhaber B., Bork P., Eisenhaber F., Post-translational GPI lipid anchor modification of proteins in kingdoms of life: analysis of protein sequence data from complete genomes. Protein Engineering 2001 14 1 17 25 2-s2.0-0035049164 (Pubitemid 32318934)
50. Swiecki M., Omattage N. S., Brett T. J., BST-2/tetherin: structural biology, viral antagonism, and immunobiology of a potent host antiviral factor. Molecular Immunology 2012 54 2 132 139
51. Haeryfar S. M. M., Hoskin D. W., Thy-1: more than a mouse pan-T cell marker. Journal of Immunology 2004 173 6 3581 3588 2-s2.0-4644229878 (Pubitemid 39280715)
52. Nosjean O., Briolay A., Roux B., Mammalian GPI proteins: sorting, membrane residence and functions. Biochimica et Biophysica Acta 1997 1331 2 153 186 2-s2.0-0030885251 10.1016/S0304-4157(97)00005-1 (Pubitemid 27387442)
53. Ferguson M. A. J., The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. Journal of Cell Science 1999 112 part 17 2799 2809 2-s2.0-0032820595 (Pubitemid 29430025)
54. Legler D. F., Doucey M. A., Schneider P., Chapatte L., Bender F. C., Bron C., Differential insertion of GPI-anchored GFPs into lipid rafts of live cells. FASEB Journal 2005 19 1 73 75 2-s2.0-11244252192 10.1096/fj.03-1338fje (Pubitemid 40069922)
55. Briggs J. A. G., Wilk T., Fuller S. D., Do lipid rafts mediate virus assembly and pseudotyping? Journal of General Virology 2003 84 part 4 757 768 2-s2.0-0037384054 10.1099/vir.0.18779-0 (Pubitemid 36432205)
56. Nguyen D. H., Hildreth J. E. K., Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. Journal of Virology 2000 74 7 3264 3272 2-s2.0-0034015604 10.1128/JVI.74.7.3264-3272.2000 (Pubitemid 30143751)
57. Dunn D. E., Yu J., Nagarajan S., Devetten M., Weichold F. F., Medof M. E., Young N. S., Liu J. M., A knock-out model of paroxysmal nocturnal hemoglobinuria: pig-a(-) hematopoiesis is reconstituted following intercellular transfer of GPI-anchored proteins. Proceedings of the National Academy of Sciences of the United States of America 1996 93 15 7938 7943 2-s2.0-0029824262
58. Kooyman D. L., Byrne G. W., McClellan S., Nielsen D., Tone M., Waldmann H., Coffman T. M., McCurry K. R., Platt J. L., Logan J. S., In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science 1995 269 5220 89 92 2-s2.0-0029001840
59. Rifkin M. R., Landsberger F. R., Trypanosome variant surface glycoprotein transfer to target membranes: a model for the pathogenesis of trypanosomiasis. Proceedings of the National Academy of Sciences of the United States of America 1990 87 2 801 805 2-s2.0-0025176633
60. Rooney I. A., Atkinson J. P., Krul E. S., Schonfeld G., Polakoski K., Saffitz J. E., Morgan B. P., Physiologic relevance of the membrane attack complex inhibitory protein CD59 in human seminal plasma: CD59 is present on extracellular organelles (prostasomes), binds cell membranes, and inhibits complement-mediated lysis. Journal of Experimental Medicine 1993 177 5 1409 1420 2-s2.0-0027478377 (Pubitemid 23117131)
61. Rooney I. A., Heuser J. E., Atkinson J. P., GPI-anchored complement regulatory proteins in seminal plasma: an analysis of their physical condition and the mechanisms of their binding to exogenous cells. Journal of Clinical Investigation 1996 97 7 1675 1686 2-s2.0-0029865964 (Pubitemid 26106233)
62. Vakeva A., Jauhiainen M., Ehnholm C., Lehto T., Meri S., High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasma. Immunology 1994 82 1 28 33 2-s2.0-0028086145 (Pubitemid 24234534)
63. Medof M. E., Nagarajan S., Tykocinski M. L., Cell-surface engineering with GPI-anchored proteins. FASEB Journal 1996 10 5 574 586 2-s2.0-0029940522 (Pubitemid 26141169)
64. Metzner C., Salmons B., Günzburg W. H., Dangerfield J. A., Rafts, anchors and viruses-a role for glycosylphosphatidylinositol anchored proteins in the modification of enveloped viruses and viral vectors. Virology 2008 382 2 125 131 2-s2.0-56349133636 10.1016/j.virol.2008.09.014
65. Laitinen O. H., Nordlund H. R., Hytönen V. P., Kulomaa M. S., Brave new (strept)avidins in biotechnology. Trends in Biotechnology 2007 25 6 269 277 2-s2.0-34248570123 10.1016/j.tibtech.2007.04.001 (Pubitemid 46755409)
66. Yang L., Bailey L., Baltimore D., Wang P., Targeting lentiviral vectors to specific cell types in vivo. Proceedings of the National Academy of Sciences of the United States of America 2006 103 31 11479 11484 2-s2.0-33746833330 10.1073/pnas.0604993103 (Pubitemid 44182477)